|
|
 Previous Article | Table of Contents | Next Article 
Detection and viability of tumor cells in peripheral blood stem cell
collections from breast cancer patients using immunocytochemical and
clonogenic assay techniques [see comments]
AA Ross, BW Cooper, HM Lazarus, W Mackay, TJ Moss, N Ciobanu, MS Tallman, MJ Kennedy, NE Davidson and D Sweet
BIS Laboratories, Reseda, CA 91335.
Although peripheral blood stem cell collections (PBSC) are thought to have
less tumor involvement than bone marrow (BM), the incidence of circulating
tumor cells in patients with breast cancer has not been widely
investigated. We prospectively investigated the incidence and viability of
tumor cell involvement in PBSC and BM collections from breast cancer
patients undergoing high-dose chemotherapy/hematopoietic stem cell
transplantation. Paired samples of PBSC and BM from 48 patients were
analyzed using an immunocytochemical technique that detects one
epithelial-derived tumor cell per 5 x 10(5) mononuclear cells.
Immunostained tumor cells were detected in 9.8% (13/133) PBSC specimens
from 9/48 (18.7%) patients and in 62.3% (38/61) BM specimens from 32/48
(66.7%) patients, a significantly higher rate than in PBSC (P < .005).
The geometric mean concentration of tumor cells in contaminated PBSC
specimens was 0.8/10(5) mononuclear cells (range 0.33 to 2.0/10(5))
compared with 22.9/10(5) mononuclear cells in BM (range 1 to 3,000/10(5), P
< .0001). In culture experiments, clonogenic tumor colonies grew in
21/26 immunocytochemically positive specimens. No tumor colony growth was
detected in 30/32 immunocytochemically negative specimens.
Immunocytochemical detection of tumor involvement in BM and PBSC correlated
significantly with in vitro clonogenic growth (P < .0001). We conclude
that PBSC contain fewer tumor cells than paired BM specimens from patients
with advanced breast cancer and that these tumor cells appear to be capable
of clonogenic growth in vitro.
Volume 82,
Issue 9,
pp. 2605-2610,
11/01/1993
Copyright © 1993 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S.-m. Yie, B. Lou, S.-r. Ye, M. Cao, X. He, P. Li, K. Hu, L. Rao, S.-m. Wu, H.-b. Xiao, et al.
Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse
Ann. Surg. Oncol.,
November 1, 2008;
15(11):
3073 - 3082.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Xi, D. G. Nicastri, T. El-Hefnawy, S. J. Hughes, J. D. Luketich, and T. E. Godfrey
Optimal Markers for Real-Time Quantitative Reverse Transcription PCR Detection of Circulating Tumor Cells from Melanoma, Breast, Colon, Esophageal, Head and Neck, and Lung Cancers
Clin. Chem.,
July 1, 2007;
53(7):
1206 - 1215.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lacroix
Significance, detection and markers of disseminated breast cancer cells
Endocr. Relat. Cancer,
December 1, 2006;
13(4):
1033 - 1067.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Mercatali, V. Valenti, D. Calistri, S. Calpona, G. Rosti, S. Folli, M. Gaudio, G. L. Frassineti, D. Amadori, and E. Flamini
RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients
Ann. Onc.,
March 1, 2006;
17(3):
424 - 428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Allard, J. Matera, M. C. Miller, M. Repollet, M. C. Connelly, C. Rao, A. G. J. Tibbe, J. W. Uhr, and L. W. M. M. Terstappen
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
Clin. Cancer Res.,
October 15, 2004;
10(20):
6897 - 6904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. F. Ferrucci, C. Rabascio, C. Mazzetta, E. Cocorocchio, A. Agazzi, A. Vanazzi, S. Cinieri, F. A. Peccatori, M. Paolucci, F. Bertolini, et al.
Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
Clin. Cancer Res.,
September 15, 2004;
10(18):
6039 - 6046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A M Gilbey, D Burnett, R E Coleman, and I Holen
The detection of circulating breast cancer cells in blood
J. Clin. Pathol.,
September 1, 2004;
57(9):
903 - 911.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Tallman, R. Gray, N. J. Robert, C. F. LeMaistre, C. K. Osborne, W. P. Vaughan, W. J. Gradishar, T. M. Pisansky, J. Fetting, E. Paietta, et al.
Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer
N. Engl. J. Med.,
July 3, 2003;
349(1):
17 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Lillo, M. Ramirez, A. Alvarez, S. Santos, J. Garcia-Castro, J. Fernandez de Velasco, M. J. Aviles, A. Gomez-Pineda, J. L. Diez, A. Balas, et al.
Efficient and Nontoxic Adenoviral Purging Method for Autologous Transplantation in Breast Cancer Patients
Cancer Res.,
September 1, 2002;
62(17):
5013 - 5018.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Fehm, A. Sagalowsky, E. Clifford, P. Beitsch, H. Saboorian, D. Euhus, S. Meng, L. Morrison, T. Tucker, N. Lane, et al.
Cytogenetic Evidence That Circulating Epithelial Cells in Patients with Carcinoma Are Malignant
Clin. Cancer Res.,
July 1, 2002;
8(7):
2073 - 2084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Solakoglu, C. Maierhofer, G. Lahr, E. Breit, P. Scheunemann, I. Heumos, U. Pichlmeier, G. Schlimok, R. Oberneder, M. W. Kollermann, et al.
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
PNAS,
February 19, 2002;
99(4):
2246 - 2251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kasimir-Bauer, S. Mayer, P. Bojko, D. Borquez, R. Neumann, and S. Seeber
Survival of Tumor Cells in Stem Cell Preparations and Bone Marrow of Patients with High-Risk or Metastatic Breast Cancer after Receiving Dose-intensive or High-Dose Chemotherapy
Clin. Cancer Res.,
June 1, 2001;
7(6):
1582 - 1589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wu, A. Mazumder, R. L. Martuza, X. Liu, M. Thein, K. R. Meehan, and S. D. Rabkin
Biological Purging of Breast Cancer Cells Using an Attenuated Replication-competent Herpes Simplex Virus in Human Hematopoietic Stem Cell Transplantation
Cancer Res.,
April 1, 2001;
61(7):
3009 - 3015.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. F. DiPersio, M. W. Schuster, C. N. Abboud, J. N. Winter, V. R. Santos, D. M. Collins, J. W. Sherman, and C. M. Baum
Mobilization of Peripheral-Blood Stem Cells by Concurrent Administration of Daniplestim and Granulocyte Colony-Stimulating Factor in Patients With Breast Cancer or Lymphoma
J. Clin. Oncol.,
July 14, 2000;
18(14):
2762 - 2771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Schröder, B.-J. Kroesen, L. F. M. H. de Leij, and E. G. E. de Vries
Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-1
Clin. Cancer Res.,
June 1, 2000;
6(6):
2521 - 2527.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Sabbatini, M. Federico, M. Morselli, R. Depenni, K. Cagossi, M. Luppi, G. Torelli, and V. Silingardi
Detection of Circulating Tumor Cells by Reverse Transcriptase Polymerase Chain Reaction of Maspin in Patients With Breast Cancer Undergoing Conventional-Dose Chemotherapy
J. Clin. Oncol.,
May 9, 2000;
18(9):
1914 - 1920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Vogel, S. Scheding, L. Kanz, and W. Brugger
Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC)
Stem Cells,
March 1, 2000;
18(2):
87 - 92.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S.-K. Kraeft, R. Sutherland, L. Gravelin, G.-H. Hu, L. H. Ferland, P. Richardson, A. Elias, and L. B. Chen
Detection and Analysis of Cancer Cells in Blood and Bone Marrow Using a Rare Event Imaging System
Clin. Cancer Res.,
February 1, 2000;
6(2):
434 - 442.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
O. N. Koc, S. L. Gerson, B. W. Cooper, S. M. Dyhouse, S. E. Haynesworth, A. I. Caplan, and H. M. Lazarus
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
J. Clin. Oncol.,
January 14, 2000;
18(2):
307 - 307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. A. Franklin, J. Glaspy, S. M. Pflaumer, R. B. Jones, L. Hami, C. Martinez, J. R. Murphy, and E. J. Shpall
Incidence of Tumor-Cell Contamination in Leukapheresis Products of Breast Cancer Patients Mobilized With Stem Cell Factor and Granulocyte Colony-Stimulating Factor (G-CSF) or With G-CSF Alone
Blood,
July 1, 1999;
94(1):
340 - 347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Offner, W. Schmaus, K. Witter, G. B. Baretton, G. Schlimok, B. Passlick, G. Riethmuller, and K. Pantel
p53 gene mutations are not required for early dissemination of cancer cells
PNAS,
June 8, 1999;
96(12):
6942 - 6946.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mohr, E. Hilgenfeld, T. Fietz, B. Hoppe, M. Koenigsmann, M. Hoffmann, W. U. Knauf, U. Cassens, W. Sibrowski, J. Kienast, et al.
Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy
Clin. Cancer Res.,
May 1, 1999;
5(5):
1035 - 1040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Spyridonidis, W. Bernhardt, D. Behringer, G. Kohler, M. Azemar, A. Pflug, and R. Henschler
Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+ Blood Progenitor Cells
Blood,
January 15, 1999;
93(2):
746 - 755.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Basser, L. B. To, J. P. Collins, C. G. Begley, D. Keefe, J. Cebon, J. Bashford, S. Durrant, J. Szer, D. Kotasek, et al.
Multicycle High-Dose Chemotherapy and Filgrastim-Mobilized Peripheral-Blood Progenitor Cells in Women With High-Risk Stage II or III Breast Cancer: Five-Year Follow-Up
J. Clin. Oncol.,
January 1, 1999;
17(1):
82 - 82.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tarella, F. Zallio, D. Caracciolo, C. Cherasco, P. Bondesan, P. Gavarotti, P. Corradini, V. Tassi, and A. Pileri
Hemopoietic Progenitor Cell Mobilization and Harvest Following an Intensive Chemotherapy Debulking in Indolent Lymphoma Patients
Stem Cells,
January 1, 1999;
17(1):
55 - 61.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Vockerodt, M. Soares, H. Kanzler, R. Kuppers, D. Kube, M.-L. Hansmann, V. Diehl, and H. Tesch
Detection of Clonal Hodgkin and Reed-Sternberg Cells With Identical Somatically Mutated and Rearranged VH Genes in Different Biopsies in Relapsed Hodgkin's Disease
Blood,
October 15, 1998;
92(8):
2899 - 2907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ketterer, G. Salles, M. Raba, D. Espinouse, A. Sonet, P. Tremisi, C. Dumontet, I. Moullet, A. Eljaafari-Corbin, E.-M. Neidhardt-Berard, et al.
High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation
Blood,
May 1, 1998;
91(9):
3148 - 3155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Racila, D. Euhus, A. J. Weiss, C. Rao, J. McConnell, L. W. M. M. Terstappen, and J. W. Uhr
Detection and characterization of carcinoma cells in the blood
PNAS,
April 14, 1998;
95(8):
4589 - 4594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Fielding, M. Maurice, F. J. Morling, F.-L. Cosset, and S. J. Russell
Inverse Targeting of Retroviral Vectors: Selective Gene Transfer in a Mixed Population of Hematopoietic and Nonhematopoietic Cells
Blood,
March 1, 1998;
91(5):
1802 - 1809.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Spyridonidis, M. Schmidt, W. Bernhardt, A. Papadimitriou, M. Azemar, W. Wels, B. Groner, and R. Henschler
Purging of Mammary Carcinoma Cells During Ex Vivo Culture of CD34+ Hematopoietic Progenitor Cells With Recombinant Immunotoxins
Blood,
March 1, 1998;
91(5):
1820 - 1827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Lowdell and P. Theocharous
"Less is More": The Role of Purging in Hematopoietic Stem Cell Transplantation
Oncologist,
August 1, 1997;
2(4):
268 - 274.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.B. To, D.N. Haylock, P.J. Simmons, and C.A. Juttner
The Biology and Clinical Uses of Blood Stem Cells
Blood,
April 1, 1997;
89(7):
2233 - 2258.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Somlo, I. Sniecinski, T. Odom-Maryon, B. Nowicki, W. Chow, V. Hamasaki, L. Leong, K. Margolin, R. Morgan Jr, J. Raschko, et al.
Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer
Blood,
March 1, 1997;
89(5):
1521 - 1528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K.W. Lie and L. B. To
Peripheral Blood Stem Cells: Transplantation and Beyond
Oncologist,
February 1, 1997;
2(1):
40 - 49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Y. Mapara, I. J. Korner, M. Hildebrandt, R. Bargou, D. Krahl, P. Reichardt, and B. Dorken
Monitoring of Tumor Cell Purging After Highly Efficient Immunomagnetic Selection of CD34 Cells From Leukapheresis Products in Breast Cancer Patients: Comparison of Immunocytochemical Tumor Cell Staining and Reverse Transcriptase-Polymerase Chain Reaction
Blood,
January 1, 1997;
89(1):
337 - 344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Korbling and R Champlin
Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts
Stem Cells,
March 1, 1996;
14(2):
185 - 195.
[Abstract]
|
|
|
|
|
|
|
B. Brockstein and S. Williams
High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow
Stem Cells,
January 1, 1996;
14(1):
79 - 89.
[Abstract]
|
|
|
|
|
|
|
T Demirer, C. Buckner, and W. Bensinger
Optimization of peripheral blood stem cell mobilization
Stem Cells,
January 1, 1996;
14(1):
106 - 116.
[Abstract]
|
|
|
|
|
